Pan-RAF Inhibition Induces Apoptosis In Acute Myeloid Leukemia Cells and Synergizes With BCL2 Inhibition

13 Jul, 2020 ,

Mahesh Tambe conducted a study to assess the efficacy Pan-RAF inhibitors of as Pan-RAF inhibitors have shown promise as antitumor agents in RAS and RAF mutated solid cancers. The researchers concluded that pan-RAF inhibition, alone or in combination with BCL2 inhibition, is a promising treatment strategy for Acute Myeloid Leukemia.